Second malignancies after multiple myeloma: from 1960s to 2010s

Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)

(2011) S. Mailankody et al.   BLOOD

Chronic Immune Stimulation Might Act As a Trigger for the Development of Acute Myeloid Leukemia or Myelodysplastic Syndromes

(2011) Sigurdur Y. Kristinsson et al.   JOURNAL OF CLINICAL ONCOLOGY

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries

(2011) Amy Berrington de Gonzalez et al.   LANCET ONCOLOGY

Myeloma and Second Primary Cancers

(2011) Ola Landgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multiple Myeloma Precursor Disease: Current Clinical Dilemma and Future Opportunities

(2011) Ola Landgren   SEMINARS IN HEMATOLOGY

Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women

(2010) O. Landgren et al.   BLOOD

Advances in the 5q- syndrome

(2010) J. Boultwood et al.   BLOOD

Risk of Myelodysplastic Syndromes in People Exposed to Ionizing Radiation: A Retrospective Cohort Study of Nagasaki Atomic Bomb Survivors

(2010) Masako Iwanaga et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma

(2010) Jens Hasskarl et al.   LEUKEMIA & LYMPHOMA

Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the Clinic

(2010) Ingemar Turesson et al.   MAYO CLINIC PROCEEDINGS

Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission

(2010) Ramin Tehranchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The relationship between multiple myeloma and occupational exposure to six chlorinated solvents

(2010) L. S. Gold et al.   OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

A role for ionizing radiation in myelomagenesis?

(2009) O. Landgren   BLOOD

A genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility

(2009) J. A. Knight et al.   BLOOD

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries

(2009) A Berrington de Gonzalez et al.   BRITISH JOURNAL OF CANCER

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

(2009) M. Jadersten et al.   HAEMATOLOGICA

Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies

(2009) S. Y. Kristinsson et al.   HAEMATOLOGICA

Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden

(2009) Sigurdur Yngvi Kristinsson et al.   JOURNAL OF CLINICAL ONCOLOGY

Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study

(2009) Ingemar Turesson et al.   JOURNAL OF CLINICAL ONCOLOGY

MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility

(2008) N. A. Ellis et al.   BLOOD

Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors

(2008) M. Iwanaga et al.   BLOOD

Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders

(2008) L. M. Brown et al.   BLOOD

Risk of New Primary Nonbreast Cancers After Breast Cancer Treatment: A Dutch Population-Based Study

(2008) Michael Schaapveld et al.   JOURNAL OF CLINICAL ONCOLOGY